Simcere Pharmaceutical Group Limited (FRA:S2P)

FRA:S2P Statistics

Total Valuation

FRA:S2P has a market cap or net worth of EUR 3.58 billion. The enterprise value is 3.40 billion.

Market Cap	3.58B
Enterprise Value	3.40B

Important Dates

The next estimated earnings date is Friday, November 14, 2025.

Earnings Date	Nov 14, 2025
Ex-Dividend Date	Jun 18, 2025

Share Statistics

Current Share Class	2.60B
Shares Outstanding	n/a
Shares Change (YoY)	-4.18%
Shares Change (QoQ)	-1.63%
Owned by Insiders (%)	4.89%
Owned by Institutions (%)	6.88%
Float	816.60M

Valuation Ratios

The trailing PE ratio is 34.22 and the forward PE ratio is 23.73.

PE Ratio	34.22
Forward PE	23.73
PS Ratio	4.24
PB Ratio	4.16
P/TBV Ratio	5.28
P/FCF Ratio	29.01
P/OCF Ratio	21.59
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 17.93, with an EV/FCF ratio of 27.59.

EV / Earnings	32.54
EV / Sales	3.94
EV / EBITDA	17.93
EV / EBIT	22.13
EV / FCF	27.59

Financial Position

The company has a current ratio of 1.73, with a Debt / Equity ratio of 0.17.

Current Ratio	1.73
Quick Ratio	1.53
Debt / Equity	0.17
Debt / EBITDA	0.79
Debt / FCF	1.18
Interest Coverage	13.37

Financial Efficiency

Return on equity (ROE) is 12.45% and return on invested capital (ROIC) is 9.55%.

Return on Equity (ROE)	12.45%
Return on Assets (ROA)	6.50%
Return on Invested Capital (ROIC)	9.55%
Return on Capital Employed (ROCE)	13.94%
Revenue Per Employee	123,947
Profits Per Employee	15,351
Employee Count	6,584
Asset Turnover	0.58
Inventory Turnover	1.91

Taxes

In the past 12 months, FRA:S2P has paid 12.78 million in taxes.

Income Tax	12.78M
Effective Tax Rate	10.88%

Stock Price Statistics

The stock price has increased by +77.07% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+77.07%
50-Day Moving Average	1.41
200-Day Moving Average	1.15
Relative Strength Index (RSI)	43.85
Average Volume (20 Days)	79

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, FRA:S2P had revenue of EUR 844.70 million and earned 104.62 million in profits. Earnings per share was 0.04.

Revenue	844.70M
Gross Profit	684.23M
Operating Income	150.37M
Pretax Income	117.40M
Net Income	104.62M
EBITDA	176.51M
EBIT	150.37M
Earnings Per Share (EPS)	0.04

Balance Sheet

The company has 318.10 million in cash and 146.15 million in debt, giving a net cash position of 171.96 million.

Cash & Cash Equivalents	318.10M
Total Debt	146.15M
Net Cash	171.96M
Net Cash Per Share	n/a
Equity (Book Value)	859.87M
Book Value Per Share	0.35
Working Capital	307.43M

Cash Flow

In the last 12 months, operating cash flow was 165.81 million and capital expenditures -42.43 million, giving a free cash flow of 123.38 million.

Operating Cash Flow	165.81M
Capital Expenditures	-42.43M
Free Cash Flow	123.38M
FCF Per Share	n/a

Margins

Gross margin is 81.00%, with operating and profit margins of 17.80% and 12.39%.

Gross Margin	81.00%
Operating Margin	17.80%
Pretax Margin	13.90%
Profit Margin	12.39%
EBITDA Margin	20.90%
EBIT Margin	17.80%
FCF Margin	14.61%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 1.36%.

Dividend Per Share	0.02
Dividend Yield	1.36%
Dividend Growth (YoY)	-7.91%
Years of Dividend Growth	1
Payout Ratio	45.61%
Buyback Yield	4.18%
Shareholder Yield	5.54%
Earnings Yield	2.92%
FCF Yield	3.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

FRA:S2P has an Altman Z-Score of 3.46 and a Piotroski F-Score of 6.

Altman Z-Score	3.46
Piotroski F-Score	6